Cookie usage

We use cookies and similar technologies on our website. In addition to services and functions that are absolutely necessary for technical reasons. Your consent is voluntary and can be changed or revoked at any time with future effect using this cookie consent tool.

I agree Change preferences
Accept only essential cookies
Site notice Privacy Policy

Select preferred cookies

These cookies are essential for the basic operation of the website and for ensuring security, including preventing bots and malicious activities. They cannot be deactivated, as they are required for functions such as user authentication, ensuring the website's security, and providing core services.

These cookies allow us to analyse how you use our website so we can continually develop and optimise your browsing experience.

Um diese Seite zu besuchen, benötigen wir Ihre Zustimmung zu Tracking durch reCAPTCHA. Durch die Aktivierung von reCAPTCHA-Cookies können wir die Website vor Spam und Missbrauch schützen, indem wir überprüfen, ob Sie ein Mensch und kein Roboter sind.

We integrate third-party editorial content – video platforms or social networking sites, for example – via iFrames or embeds on our website. These external services may use your data to analyse your online behaviour when you view this content on our site. We have no say over whether or how third parties use your data.

Save selection
Site notice Privacy Policy

Cookie-Einstellungen

  • Home
  • Presse
  • WR-Intern
  • Der Critical Medicines Act – Europas Antwort auf Medikamentenengpässe
WR-Intern
03.04.2025
Drucken

Der Critical Medicines Act – Europas Antwort auf Medikamentenengpässe

Ein neuer Gesetzesrahmen für kritische Arzneimittel soll die Abhängigkeit von außereuropäischen Herstellern reduzieren und die Medikamentenverfügbarkeit sichern
©None
Drucken

Schlagworte